MERIT MEDICAL SYSTEMS INC

NASDAQ: MMSI (Merit Medical Systems, Inc.)

Last update: 25 Aug, 12:25PM

88.31

-1.14 (-1.27%)

Previous Close 89.45
Open 89.01
Volume 166,740
Avg. Volume (3M) 611,206
Market Cap 5,229,638,656
Price / Earnings (TTM) 44.83
Price / Earnings (Forward) 26.88
Price / Sales 3.82
Price / Book 3.60
52 Weeks Range
81.04 (-8%) — 111.45 (26%)
Earnings Date 30 Oct 2025
Profit Margin 8.81%
Operating Margin (TTM) 11.83%
Diluted EPS (TTM) 2.04
Quarterly Revenue Growth (YOY) 9.80%
Quarterly Earnings Growth (YOY) 6.80%
Total Debt/Equity (MRQ) 57.24%
Current Ratio (MRQ) 4.87
Operating Cash Flow (TTM) 225.16 M
Levered Free Cash Flow (TTM) 172.75 M
Return on Assets (TTM) 4.32%
Return on Equity (TTM) 9.16%

Market Trend

Short Term Medium Term
Industry Medical Instruments & Supplies (US) Mixed Bearish
Medical Instruments & Supplies (Global) Bearish Bearish
Stock Merit Medical Systems, Inc. Bearish Bearish

AIStockmoo Score

2.1
Analyst Consensus 2.0
Insider Activity -1.5
Price Volatility 4.5
Technical Moving Averages 3.5
Technical Oscillators 2.0
Average 2.10

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
MMSI 5 B - 44.83 3.60
LMAT 2 B 0.59% 46.52 6.26
ATRC 2 B - - 3.99
AZTA 1 B - - 0.840
PLSE 1 B - - 10.01
STAA 916 M - - 4.03

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Sector Healthcare
Industry Medical Instruments & Supplies
Investment Style Small Growth
% Held by Insiders 2.23%
% Held by Institutions 109.41%
52 Weeks Range
81.04 (-8%) — 111.45 (26%)
Price Target Range
100.00 (13%) — 108.00 (22%)
High 108.00 (Needham, 22.30%) Buy
Median 103.00 (16.64%)
Low 100.00 (Wells Fargo, 13.24%) Buy
Average 103.60 (17.31%)
Total 5 Buy
Avg. Price @ Call 84.49
Firm Date Target Price Call Price @ Call
Barrington Research 31 Jul 2025 103.00 (16.63%) Buy 84.86
Piper Sandler 31 Jul 2025 105.00 (18.90%) Buy 84.86
Raymond James 31 Jul 2025 102.00 (15.50%) Buy 84.86
Wells Fargo 31 Jul 2025 100.00 (13.24%) Buy 84.86
Needham 18 Jul 2025 108.00 (22.30%) Buy 83.02
08 Jul 2025 108.00 (22.30%) Buy 95.34
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
WARD LYNNE N. - 89.45 -3,000 -268,350
Aggregate Net Quantity -3,000
Aggregate Net Value ($) -268,350
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 89.45
Name Holder Date Type Quantity Price Value ($)
WARD LYNNE N. Director 22 Aug 2025 Sell (-) 3,000 89.45 268,350
WARD LYNNE N. Director 22 Aug 2025 Option execute 3,000 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria